The IRIS Valve, whose design allows it to expand as patients grow, could potentially improve outcomes for children with congenital heart disease.
CHOC-led study explores cardiac MRI for borderline left ventricle surgery
The new study is an example of how CHOC and UCLA Health are transforming the way cardiac care is being delivered in Southern California.
Surveillance program for patients with congenital heart disease a success
In novel program, congenital heart disease patients are being monitored at CHOC for longtime success.
New guidelines for targeted echocardiography improve neonatal outcomes
Growth in the field of targeted neonatal echocardiography is helping neonatologists diagnose and treat critical illnesses more quickly.
‘First of its kind’ pulmonary valve ‘grows’ with patients
Children who need pulmonary valve replacement benefit from surgery. The IRIS valve is built small enough to implant in very young patients.
CHOC-UCLA Health team mobilizes to save 13-year-old football player with undetected congenital heart problem
CHOC and UCLA Health’s treatment of a teen with anomalous left coronary artery (ALCA) exemplifies the unique joint pediatric heart program.
